The market for continuous glucose monitoring systems, where companies such as Abbott Laboratories (ABT) and DexCom (NASDAQ:DXCM) dominate, is expected to reach $31.7B by 2031, Allied Market Research said in a recent industry report.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased